Royal Bank of Canada’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-78
| Closed | – | – | 7213 |
|
|
2025
Q4 | $0 | Sell |
78
-501,552
| -100% | -$2.57M | ﹤0.01% | 7239 |
|
|
2025
Q3 | $2.7M | Buy |
501,630
+491,997
| +5,107% | +$2.66M | ﹤0.01% | 3155 |
|
|
2025
Q2 | $52K | Sell |
9,633
-10,075
| -51% | -$40K | ﹤0.01% | 5899 |
|
|
2025
Q1 | $54K | Buy |
19,708
+14,034
| +247% | +$48.8K | ﹤0.01% | 5539 |
|
|
2024
Q4 | $19K | Sell |
5,674
-8,787
| -61% | -$25.3K | ﹤0.01% | 6123 |
|
|
2024
Q3 | $42K | Buy |
14,461
+2,493
| +21% | +$8.21K | ﹤0.01% | 5783 |
|
|
2024
Q2 | $41K | Buy |
11,968
+4,035
| +51% | +$13.2K | ﹤0.01% | 5745 |
|
|
2024
Q1 | $24K | Buy |
7,933
+865
| +12% | +$3.04K | ﹤0.01% | 5837 |
|
|
2023
Q4 | $29K | Sell |
7,068
-10,001
| -59% | -$54.2K | ﹤0.01% | 6193 |
|
|
2023
Q3 | $116K | Buy |
17,069
+1,984
| +13% | +$17.5K | ﹤0.01% | 5283 |
|
|
2023
Q2 | $157K | Buy |
15,085
+2,042
| +16% | +$18.3K | ﹤0.01% | 4958 |
|
|
2023
Q1 | $91K | Buy |
13,043
+9,300
| +248% | +$81.1K | ﹤0.01% | 5250 |
|
|
2022
Q4 | $22K | Sell |
3,743
-7,376
| -66% | -$54.5K | ﹤0.01% | 6256 |
|
|
2022
Q3 | $87K | Buy |
11,119
+1,280
| +13% | +$14.9K | ﹤0.01% | 5398 |
|
|
2022
Q2 | $133K | Sell |
9,839
-2,560
| -21% | -$42.3K | ﹤0.01% | 5130 |
|
|
2022
Q1 | $243K | Sell |
12,399
-818
| -6% | -$16.3K | ﹤0.01% | 4913 |
|
|
2021
Q4 | $453K | Buy |
13,217
+7,041
| +114% | +$283K | ﹤0.01% | 4556 |
|
|
2021
Q3 | $339K | Buy |
6,176
+4,348
| +238% | +$262K | ﹤0.01% | 4674 |
|
|
2021
Q2 | $134K | Buy |
1,828
+1,321
| +261% | +$132K | ﹤0.01% | 5404 |
|
|
2021
Q1 | $46K | Sell |
507
-2,934
| -85% | -$285K | ﹤0.01% | 5930 |
|
|
2020
Q4 | $280K | Buy |
3,441
+41
| +1% | +$3.14K | ﹤0.01% | 4603 |
|
|
2020
Q3 | $159K | Buy |
+3,400
| New | +$190K | ﹤0.01% | 4695 |
|
Royal Bank of Canada's CVAC Position: Q1 2026 in Review
Royal Bank of Canada sold out of CureVac (CVAC) in Q1 2026, closing a stake of 78 shares.
Royal Bank of Canada first reported a position in CVAC in Q3 2020 and held it in 22 quarters. The position peaked at $2.7M in Q3 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- Royal Bank of Canada reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- Royal Bank of Canada sold 78 CureVac shares in Q1 2026.
- Royal Bank of Canada first reported a position in CureVac in Q3 2020 and held it in 22 quarters.
- Royal Bank of Canada's CureVac position peaked at $2.7M in Q3 2025.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.